Skip to content

Genetic Risk and Health Coaching for Type 2 Diabetes and Coronary Heart Disease

Genetic Risk and Health Coaching for Type 2 Diabetes and Coronary Heart Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01884545
Enrollment
220
Registered
2013-06-24
Start date
2013-07-31
Completion date
2017-02-01
Last updated
2018-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Heart Disease, Susceptibility to, 5, Prediabetic State

Keywords

heart disease, type 2 diabetes, genetic testing, health coaching, risk assessment

Brief summary

The purpose of this study is to examine whether the use of genetic test information and/or health coaching in patient risk counseling for heart disease and diabetes affect health behaviors and health outcomes in active-duty Air Force (ADAF), beneficiaries or dependents and Air Force retiree patients. Total of 400 subjects will be enrolled. They will be randomly(like flipping a coin)assigned to 4 groups: 1)Standard risk assessment (SRA)only; 2)SRA plus genetic risk information (SRA+G); 3)SRA plus health coaching (SRA+HC); or 4)SRA, genetic risk information, and health coaching (SRA+G+HC). Subjects randomized to the two genetic arms will have blood collected for testing of investigational coronary heart disease (CHD) and type 2 diabetes (T2D) risk markers. Participants in the two groups that include health coaching will be assigned to a trained certified health coach for a period of 6 months. The duration of the study is 12 months with 3 in person visits (baseline, 6 months and 12 months) and completion of surveys at 6 weeks and 3 month time points.

Detailed description

This study will examine the impact of providing genetic CHD and T2D risk information, with or without a supportive behavioral intervention, on promoting risk-reducing behaviors and improving clinical outcomes. In short, using a 4-group (2X2) randomized controlled trial (RCT) design, this study will determine whether incorporating multiple-marker genetic testing into risk counseling for CHD and T2D, coupled with a health coaching intervention will lead to greater changes in physical fitness, health behaviors, risk status and clinical outcomes in active-duty Air Force (ADAF), beneficiaries or dependents and AF retiree patients (N=400). The study will address the following task objectives: 1. Determine the main and interactive effects of multiple-marker genetic risk information incorporated into standard CHD and T2D risk counseling (Standard Risk Assessment, or SRA) and an established, structured telephonic health coaching intervention on health behavior change (diet, exercise habits, smoking cessation) over 12 months, with a focus on ADAF patients, as well as their beneficiaries and retirees. 2. Determine the main and interactive effects of genetic risk information incorporated into standard CHD and T2D risk counseling and a telephonic health coaching intervention on clinical outcomes (fasting blood glucose, blood pressure, BMI, LDL, triglycerides, total cholesterol, AF composite fitness scores) over 12 months in this AF cohort. Given the lack of RCTs on the effects of differing genetic test results, such as false reassurance and genetic determinism, we will also pursue a third, exploratory task objective: 3. Examine the differential effects of level of CHD and T2D genetic risk (# of risk alleles) on behavior change (diet, exercise habits, smoking cessation) and AF fitness scores at 12 months post baseline. Baseline data collection: After screening and informed consent, height and weight, SBP, waist circumference, current lab results (FPG, total cholesterol, triglycerides, LDL, HbA1c, and HDL) and current PHA (physical health assessment) data with fitness scores ( for active duty personnel only) will be obtained from the medical records. Subjects randomized to the two genetic arms will have blood collected for testing of investigational CHD and T2D risk markers. Randomization will take place to one of the following: SRA only; SRA plus genetic risk information (SRA+G); SRA plus health coaching (SRA+HC); or SRA, genetic risk information, and health coaching (SRA+G+HC). Risk Counseling Visit: Within four weeks after the baseline visit all participants will receive risk counseling with trained provider(s) at each clinic site. Health coaching intervention: Participants in the two groups that include health coaching will be assigned to a trained health coach for a period of 6 months (n=200). IHC (Integrative Health Coaching) sessions will be provided by telephone using a structure that has evolved in multiple trials and clinical programs at Duke Integrative Medicine. Six week, 3-, and 6-month follow-ups: At 6 weeks, 3 months and 6 months after the baseline visit, participants will be asked to complete selected surveys online. 6month and 12 month study visits: 12 months from the baseline visit, active duty participants will complete their annual PHA, required annual AF fitness testing; and all participants will complete study visits at 6 and 12 months for weight, waist circumference, BP, fasting glucose or HbA1c and lipid panels to be re-assessed. Surveys will be completed at or prior to the final 12 month visit as well.

Interventions

BEHAVIORALHealth coaching

Telephonic health coaching sessions with a trained certified health coach for a period of 6 months (total of 10 biweekly calls).

GENETICGenetic risk counseling

In addition to the SRA subjects will receive genetic risk counseling at the risk counseling visit with a clinic provider. Genetic test results for CHD (rs10757274) and T2D (rs7903146, rs1801282, rs5219) risk variants will be incorporated into the risk profile reviewed with subjects.

Standard risk assessment for coronary heart disease (CHD) and type 2 diabetes (T2D). Standard risk factors are reviewed by a provider at a risk counseling visit with the subject.

Sponsors

David Grant U.S. Air Force Medical Center
CollaboratorFED
Duke University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 18 to 65 years * Willingness and ability to provide informed consent * Have an active email address and internet access * Physical exam in the last 12 months with the following documented evaluations in EMR (Electronic Medical record): 1. Blood pressure 2. Height and weight 3. Fasting blood glucose or Hemoglobin A1C (HbA1c) 4. Lipid panel (TC, LDL, HDL, TRIG) with at least one of them outside of the normal ranges defined as: i.BMI ≥ 25 kg/m2 (BMI = weight \[kg\] / ht \[m\]2) ii.FPG \> 100 AND ≤ 125 mg/dL iii.HbA1c \> 5.7% ≤ 6.4% iv.SBP ≥ 130 mmHg v.TC ≥ 200 mg/dL vi.TRIG ≥ 150 mg/dL vii.LDL ≥ 129 mg/dL

Exclusion criteria

* Projected deployment in the upcoming 6 months * Diagnosed type 2 diabetes * Diagnosed coronary heart disease (CHD) -(Myocardial Infarction, or documented CHD) * Inability to ambulate or participate in physical activity * Serious chronic disease related complications or conditions that could significantly affect study outcomes \[currently treated cancer, renal failure, cardiovascular accident (CVA) with residual effects on functioning * Current participation in another research study * Spouse, partner or other household member already participating in this study protocol

Design outcomes

Primary

MeasureTime frameDescription
Dietary Intake as Measured by Percent Energy From Fat12 monthsDietary intake as measured by percent energy from fat, adjusted for baseline
Dietary Intake as Measured by Daily Grams of Fiber12 monthsDietary intake as measured by daily grams of fiber, adjusted for baseline
Physical Activity, as Measured by the Stanford Brief Activity Survey (SBAS)12 monthsThe Stanford Brief Activity Survey is a 2-item survey that assesses two categories of physical activity - work and leisure. There are five options for degree of activity to choose from in each of the two areas of activity. Activity categories (inactive, light-intensity activity, moderate-intensity activity, hard-intensity activity, and very hard-intensity) are represented in a table of different patterns. Degree of work activity is represented on the vertical axis and degree of leisure activity is represented on the horizontal axis. The overall activity level category is determined by where the two responses intersect.
Smoking Status12 months
Medication Adherence as Measured by Morisky Adherence Survey MMAS812 monthsScores of the MMAS-8 range from 0 to 8. A score below 6 indicates low adherence, a score between 6 \< 8 medium adherence and a score of 8 high adherence.
Weight12 monthsWeight in kg
Waist Circumference12 monthsWaist circumference in cm
Systolic Blood Pressure12 monthsSystolic blood pressure in mmHg
Diastolic Blood Pressure12 monthsDiastolic blood pressure in mmHg
High-density Lipoprotein (HDL)12 monthsHigh-density lipoprotein (HDL) in mg/dL
Low-density Lipoprotein (LDL)12 monthsLow-density lipoprotein (LDL) in mg/dL
Triglycerides12 monthsTriglycerides in mg/dL

Secondary

MeasureTime frameDescription
Fasting Blood Glucose12 monthsAdjusted for baseline
Social Isolation6 monthsSingle item to assess for availability of support person, where No=no support person.
Body Mass Index (BMI)12 months
Total Cholesterol12 monthsAdjusted for baseline
AF Composite Fitness Scores12 monthsLast annual fitness exam result, collected as pass or fail
Framingham Risk Score (FRS)12 months
Diabetes Risk Score12 months
Perceived Risk for Coronary Heart Disease (CHD)6 monthsInvestigator developed questions assessing level of personal perceived risk, fear, anger, worry regarding CHD risk. The consequences subscale ranges from 6-30. Higher scores on the consequences represent strongly held beliefs about negative consequences of the illness. The personal control subscale ranges from 6-30 and the treatment control subscale ranges from 2-10. Higher scores on the personal control and treatment control represent positive beliefs about the controllability of the illness. The emotional representations scores range from 6-30. Higher score indicates higher levels of worry or anxiety about risk of illness.
Perceived Risk for Type 2 Diabetes (T2D)6 monthsInvestigator developed questions assessing level of personal perceived risk, fear, anger, worry regarding T2D risk. The consequences subscale ranges from 6-30. Higher scores on the consequences represent strongly held beliefs about negative consequences of the illness. The personal control subscale ranges from 6-30 and the treatment control subscale ranges from 2-10. Higher scores on the personal control and treatment control represent positive beliefs about the controllability of the illness. The emotional representations scores range from 6-30. Higher score indicates higher levels of worry or anxiety about risk of illness.
Patient Activation Score12 monthsPatient activation is the degree to which patients accept an active role in their healthcare, and have the knowledge, skills and confidence to take care of their health. When scored as a continuous variable, the range is from 0 to 100, with higher numbers indicating greater levels of patient activation.
Stages of Change6 monthsThese evidence-based questions are validated and based upon the Transtheoretical Model and assess an individual's readiness to make behavioral change in 5 health behavior domains (dietary intake, exercise, weight loss, smoking cessation, and medication adherence).
Depression, as Measured by the Beck Depression Inventory (BDI)6 monthsThe Beck Depression Inventory is a 21-item measure that assesses self-reported symptoms of depression. It has been heavily used in research linking depression to heart disease. Scores range from 0-63, with 0 = minimal depression and 63 = severe depression.
Unmanaged Stress as Measured by the Perceived Stress Scale (PSS)6 monthsThe PSS is a 10 item survey assessing feelings and thoughts of stress. Scores range from 0-40 with higher scores indicating higher perceived stress.

Countries

United States

Participant flow

Pre-assignment details

220 subjects were consented. Prior to randomization 9 subjects withdrew from the study, 10 were lost to follow up, and 1 did not meet inclusion criteria. 200 participants were randomized.

Participants by arm

ArmCount
Standard Risk Assessment (SRA)
Subjects will receive a standard risk assessment only for coronary heart disease (CHD) and type 2 diabetes (T2D). Standard risk factors are reviewed by a provider at a risk counseling visit with the subject. Standard risk assessment: Standard risk assessment for coronary heart disease (CHD) and type 2 diabetes (T2D). Standard risk factors are reviewed by a provider at a risk counseling visit with the subject.
50
SRA Plus Health Coaching (HC)
In addition to the standard risk assessment for CHD and T2D subjects will receive health coaching intervention for 6 months Health coaching: Telephonic health coaching sessions with a trained certified health coach for a period of 6 months (total of 10 biweekly calls). Standard risk assessment: Standard risk assessment for coronary heart disease (CHD) and type 2 diabetes (T2D). Standard risk factors are reviewed by a provider at a risk counseling visit with the subject.
49
SRA Plus Genetic Risk Counseling (GRC)
In addition to the SRA subjects will receive genetic risk counseling at the risk counseling visit with a clinic provider. Genetic test results for CHD (rs10757274) and T2D (rs7903146, rs1801282, rs5219) risk variants will be incorporated into the risk profile reviewed with subjects. Genetic risk counseling: In addition to the SRA subjects will receive genetic risk counseling at the risk counseling visit with a clinic provider. Genetic test results for CHD (rs10757274) and T2D (rs7903146, rs1801282, rs5219) risk variants will be incorporated into the risk profile reviewed with subjects. Standard risk assessment: Standard risk assessment for coronary heart disease (CHD) and type 2 diabetes (T2D). Standard risk factors are reviewed by a provider at a risk counseling visit with the subject.
49
SRA+HC+GRC
In addition to the standard risk assessment for CHD and T2D subjects will receive genetic risk counseling and health coaching intervention for 6 months. Health coaching: Telephonic health coaching sessions with a trained certified health coach for a period of 6 months (total of 10 biweekly calls). Genetic risk counseling: In addition to the SRA subjects will receive genetic risk counseling at the risk counseling visit with a clinic provider. Genetic test results for CHD (rs10757274) and T2D (rs7903146, rs1801282, rs5219) risk variants will be incorporated into the risk profile reviewed with subjects. Standard risk assessment: Standard risk assessment for coronary heart disease (CHD) and type 2 diabetes (T2D). Standard risk factors are reviewed by a provider at a risk counseling visit with the subject.
52
Total200

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003
Overall StudyLost to Follow-up6494
Overall StudyNon-adherence0200
Overall StudyPatient withdrawn71255

Baseline characteristics

CharacteristicTotalSRA+HC+GRCSRA Plus Genetic Risk Counseling (GRC)SRA Plus Health Coaching (HC)Standard Risk Assessment (SRA)
Age, Continuous47.72 years
STANDARD_DEVIATION 11.56
44.85 years
STANDARD_DEVIATION 11.85
48.35 years
STANDARD_DEVIATION 10.51
48.67 years
STANDARD_DEVIATION 12.67
49.16 years
STANDARD_DEVIATION 10.92
Diastolic Blood Pressure80.12 mmHg
STANDARD_DEVIATION 9.63
80.62 mmHg
STANDARD_DEVIATION 10.7
78.26 mmHg
STANDARD_DEVIATION 8.36
80.77 mmHg
STANDARD_DEVIATION 10.38
80.78 mmHg
STANDARD_DEVIATION 8.89
Dietary Intake (Daily grams of fiber)16.46 grams
STANDARD_DEVIATION 6.73
18.27 grams
STANDARD_DEVIATION 8.68
15.75 grams
STANDARD_DEVIATION 5.83
14.94 grams
STANDARD_DEVIATION 5.57
16.65 grams
STANDARD_DEVIATION 5.82
Dietary Intake (Percent energy from fat)34.81 percent
STANDARD_DEVIATION 4.14
35.66 percent
STANDARD_DEVIATION 4.91
34.13 percent
STANDARD_DEVIATION 4.55
34.87 percent
STANDARD_DEVIATION 3.17
34.50 percent
STANDARD_DEVIATION 3.6
Ethnicity (NIH/OMB)
Hispanic or Latino
18 Participants5 Participants2 Participants3 Participants8 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
179 Participants47 Participants47 Participants45 Participants40 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
3 Participants0 Participants0 Participants1 Participants2 Participants
High-density Lipoprotein (HDL)52.53 mg/dL
STANDARD_DEVIATION 16.62
50.50 mg/dL
STANDARD_DEVIATION 16.41
49.59 mg/dL
STANDARD_DEVIATION 13.5
56.45 mg/dL
STANDARD_DEVIATION 18.62
53.66 mg/dL
STANDARD_DEVIATION 17.15
Low-density Lipoprotein (LDL)134.05 mg/dL
STANDARD_DEVIATION 36.12
136.95 mg/dL
STANDARD_DEVIATION 37.15
131.94 mg/dL
STANDARD_DEVIATION 32.9
133.51 mg/dL
STANDARD_DEVIATION 42.4
133.63 mg/dL
STANDARD_DEVIATION 32.05
Medication Adherence (Morisky 4)
High Adherence
56 Participants15 Participants11 Participants17 Participants13 Participants
Medication Adherence (Morisky 4)
Low Adherence
61 Participants14 Participants19 Participants12 Participants16 Participants
Medication Adherence (Morisky 4)
Medium Adherence
52 Participants15 Participants12 Participants12 Participants13 Participants
Medication Adherence (Morisky 4)
Not applicable (patient not taking medication)
30 Participants8 Participants7 Participants7 Participants8 Participants
Physical Activity
Inactive/light intensity activity
96 Participants25 Participants25 Participants20 Participants26 Participants
Physical Activity
Moderate/ hard/very hard intensity activity
104 Participants27 Participants24 Participants29 Participants24 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants1 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
39 Participants5 Participants13 Participants12 Participants9 Participants
Race (NIH/OMB)
Black or African American
29 Participants6 Participants7 Participants8 Participants8 Participants
Race (NIH/OMB)
More than one race
3 Participants1 Participants1 Participants0 Participants1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
4 Participants0 Participants2 Participants0 Participants2 Participants
Race (NIH/OMB)
Unknown or Not Reported
5 Participants3 Participants1 Participants0 Participants1 Participants
Race (NIH/OMB)
White
119 Participants36 Participants25 Participants29 Participants29 Participants
Region of Enrollment
United States
200 Participants52 Participants49 Participants49 Participants50 Participants
Sex: Female, Male
Female
98 Participants20 Participants31 Participants25 Participants22 Participants
Sex: Female, Male
Male
102 Participants32 Participants18 Participants24 Participants28 Participants
Smoking Status
No
178 Participants43 Participants44 Participants46 Participants45 Participants
Smoking Status
Yes
22 Participants9 Participants5 Participants3 Participants5 Participants
Systolic Blood Pressure126.77 mmHg
STANDARD_DEVIATION 12.24
128.68 mmHg
STANDARD_DEVIATION 13.3
123.24 mmHg
STANDARD_DEVIATION 10.87
126.41 mmHg
STANDARD_DEVIATION 13.03
128.60 mmHg
STANDARD_DEVIATION 11.06
Triglycerides160.24 mg/dL
STANDARD_DEVIATION 90.33
156.60 mg/dL
STANDARD_DEVIATION 69.44
157.35 mg/dL
STANDARD_DEVIATION 87.76
150.73 mg/dL
STANDARD_DEVIATION 70.53
176.19 mg/dL
STANDARD_DEVIATION 123.8
Waist Circumference98.30 cm
STANDARD_DEVIATION 13.23
98.56 cm
STANDARD_DEVIATION 12.09
97.23 cm
STANDARD_DEVIATION 13.5
98.51 cm
STANDARD_DEVIATION 16.42
98.86 cm
STANDARD_DEVIATION 10.73
Weight85.58 kg
STANDARD_DEVIATION 18.15
89.07 kg
STANDARD_DEVIATION 17.76
84.96 kg
STANDARD_DEVIATION 20.66
82.15 kg
STANDARD_DEVIATION 16.75
85.94 kg
STANDARD_DEVIATION 17.05

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 500 / 490 / 490 / 52
other
Total, other adverse events
0 / 500 / 490 / 490 / 52
serious
Total, serious adverse events
0 / 501 / 490 / 490 / 52

Outcome results

Primary

Diastolic Blood Pressure

Diastolic blood pressure in mmHg

Time frame: 12 months

Population: Randomization Arms/Groups were regrouped as pre-specified in the study protocol

ArmMeasureValue (MEAN)Dispersion
Health CoachingDiastolic Blood Pressure79.79 mmHgStandard Deviation 0.95
Non-Health CoachingDiastolic Blood Pressure79.38 mmHgStandard Deviation 0.98
Genetic Risk CounselingDiastolic Blood Pressure79.59 mmHgStandard Deviation 0.95
Non-Genetic Risk CounselingDiastolic Blood Pressure79.59 mmHgStandard Deviation 0.99
p-value: 0.7639Regression, Linear
p-value: 0.9999Regression, Linear
Primary

Dietary Intake as Measured by Daily Grams of Fiber

Dietary intake as measured by daily grams of fiber, adjusted for baseline

Time frame: 12 months

Population: Randomization Arms/Groups were regrouped as pre-specified in the study protocol

ArmMeasureValue (MEAN)Dispersion
Health CoachingDietary Intake as Measured by Daily Grams of Fiber15.69 gramsStandard Deviation 0.51
Non-Health CoachingDietary Intake as Measured by Daily Grams of Fiber15.38 gramsStandard Deviation 0.51
Genetic Risk CounselingDietary Intake as Measured by Daily Grams of Fiber15.24 gramsStandard Deviation 0.49
Non-Genetic Risk CounselingDietary Intake as Measured by Daily Grams of Fiber15.89 gramsStandard Deviation 0.54
p-value: 0.6732Regression, Linear
p-value: 0.3754Regression, Linear
Primary

Dietary Intake as Measured by Percent Energy From Fat

Dietary intake as measured by percent energy from fat, adjusted for baseline

Time frame: 12 months

Population: Randomization Arms/Groups were regrouped as pre-specified in the study protocol

ArmMeasureValue (MEAN)Dispersion
Health CoachingDietary Intake as Measured by Percent Energy From Fat33.75 percent energy from fatStandard Deviation 0.5
Non-Health CoachingDietary Intake as Measured by Percent Energy From Fat34.9 percent energy from fatStandard Deviation 0.5
Genetic Risk CounselingDietary Intake as Measured by Percent Energy From Fat33.72 percent energy from fatStandard Deviation 0.47
Non-Genetic Risk CounselingDietary Intake as Measured by Percent Energy From Fat35.05 percent energy from fatStandard Deviation 0.52
p-value: 0.1073Regression, Linear
p-value: 0.0615Regression, Linear
Primary

High-density Lipoprotein (HDL)

High-density lipoprotein (HDL) in mg/dL

Time frame: 12 months

Population: Randomization Arms/Groups were regrouped as pre-specified in the study protocol

ArmMeasureValue (MEAN)Dispersion
Health CoachingHigh-density Lipoprotein (HDL)54.27 mg/dLStandard Deviation 0.93
Non-Health CoachingHigh-density Lipoprotein (HDL)53.3 mg/dLStandard Deviation 0.96
Genetic Risk CounselingHigh-density Lipoprotein (HDL)53.02 mg/dLStandard Deviation 0.93
Non-Genetic Risk CounselingHigh-density Lipoprotein (HDL)54.67 mg/dLStandard Deviation 0.99
p-value: 0.4673Regression, Linear
p-value: 0.2297Regression, Linear
Primary

Low-density Lipoprotein (LDL)

Low-density lipoprotein (LDL) in mg/dL

Time frame: 12 months

Population: Randomization Arms/Groups were regrouped as pre-specified in the study protocol

ArmMeasureValue (MEAN)Dispersion
Health CoachingLow-density Lipoprotein (LDL)128.62 mg/dLStandard Deviation 3.5
Non-Health CoachingLow-density Lipoprotein (LDL)122.42 mg/dLStandard Deviation 3.6
Genetic Risk CounselingLow-density Lipoprotein (LDL)125.33 mg/dLStandard Deviation 3.47
Non-Genetic Risk CounselingLow-density Lipoprotein (LDL)125.93 mg/dLStandard Deviation 3.68
p-value: 0.2192Regression, Linear
p-value: 0.9062Regression, Linear
Primary

Medication Adherence as Measured by Morisky Adherence Survey MMAS8

Scores of the MMAS-8 range from 0 to 8. A score below 6 indicates low adherence, a score between 6 \< 8 medium adherence and a score of 8 high adherence.

Time frame: 12 months

Population: Randomization Arms/Groups were regrouped as pre-specified in the study protocol

ArmMeasureValue (MEAN)Dispersion
Health CoachingMedication Adherence as Measured by Morisky Adherence Survey MMAS86.66 units on a scaleStandard Deviation 0.19
Non-Health CoachingMedication Adherence as Measured by Morisky Adherence Survey MMAS86.59 units on a scaleStandard Deviation 0.18
Genetic Risk CounselingMedication Adherence as Measured by Morisky Adherence Survey MMAS86.79 units on a scaleStandard Deviation 0.17
Non-Genetic Risk CounselingMedication Adherence as Measured by Morisky Adherence Survey MMAS86.43 units on a scaleStandard Deviation 0.19
p-value: 0.7985Regression, Linear
p-value: 0.1642Regression, Linear
Primary

Physical Activity, as Measured by the Stanford Brief Activity Survey (SBAS)

The Stanford Brief Activity Survey is a 2-item survey that assesses two categories of physical activity - work and leisure. There are five options for degree of activity to choose from in each of the two areas of activity. Activity categories (inactive, light-intensity activity, moderate-intensity activity, hard-intensity activity, and very hard-intensity) are represented in a table of different patterns. Degree of work activity is represented on the vertical axis and degree of leisure activity is represented on the horizontal axis. The overall activity level category is determined by where the two responses intersect.

Time frame: 12 months

Population: Randomization Arms/Groups were regrouped as pre-specified in the study protocol. Some participants were not analyzed because data were missing.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Health CoachingPhysical Activity, as Measured by the Stanford Brief Activity Survey (SBAS)Inative/light intensity activity25 Participants
Health CoachingPhysical Activity, as Measured by the Stanford Brief Activity Survey (SBAS)hard/very hard intensity activity17 Participants
Health CoachingPhysical Activity, as Measured by the Stanford Brief Activity Survey (SBAS)moderate intensity activity30 Participants
Non-Health CoachingPhysical Activity, as Measured by the Stanford Brief Activity Survey (SBAS)Inative/light intensity activity41 Participants
Non-Health CoachingPhysical Activity, as Measured by the Stanford Brief Activity Survey (SBAS)hard/very hard intensity activity13 Participants
Non-Health CoachingPhysical Activity, as Measured by the Stanford Brief Activity Survey (SBAS)moderate intensity activity18 Participants
Genetic Risk CounselingPhysical Activity, as Measured by the Stanford Brief Activity Survey (SBAS)moderate intensity activity23 Participants
Genetic Risk CounselingPhysical Activity, as Measured by the Stanford Brief Activity Survey (SBAS)Inative/light intensity activity34 Participants
Genetic Risk CounselingPhysical Activity, as Measured by the Stanford Brief Activity Survey (SBAS)hard/very hard intensity activity20 Participants
Non-Genetic Risk CounselingPhysical Activity, as Measured by the Stanford Brief Activity Survey (SBAS)Inative/light intensity activity32 Participants
Non-Genetic Risk CounselingPhysical Activity, as Measured by the Stanford Brief Activity Survey (SBAS)hard/very hard intensity activity10 Participants
Non-Genetic Risk CounselingPhysical Activity, as Measured by the Stanford Brief Activity Survey (SBAS)moderate intensity activity25 Participants
p-value: 0.007395% CI: [1.326, 6.139]Regression, Logistic
p-value: 0.906895% CI: [0.5, 2.183]Regression, Logistic
Primary

Smoking Status

Time frame: 12 months

Population: Randomization Arms/Groups were regrouped as pre-specified in the study protocol. Some participants were not analyzed because data were missing.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Health CoachingSmoking StatusSmoked in the last 30 days = No65 Participants
Health CoachingSmoking StatusSmoked in the last 30 days = Yes4 Participants
Non-Health CoachingSmoking StatusSmoked in the last 30 days = Yes3 Participants
Non-Health CoachingSmoking StatusSmoked in the last 30 days = No63 Participants
Genetic Risk CounselingSmoking StatusSmoked in the last 30 days = No67 Participants
Genetic Risk CounselingSmoking StatusSmoked in the last 30 days = Yes4 Participants
Non-Genetic Risk CounselingSmoking StatusSmoked in the last 30 days = No61 Participants
Non-Genetic Risk CounselingSmoking StatusSmoked in the last 30 days = Yes3 Participants
p-value: 0.782295% CI: [0.173, 10.254]Regression, Logistic
p-value: 0.782295% CI: [0.173, 10.254]Regression, Logistic
Primary

Systolic Blood Pressure

Systolic blood pressure in mmHg

Time frame: 12 months

Population: Randomization Arms/Groups were regrouped as pre-specified in the study protocol

ArmMeasureValue (MEAN)Dispersion
Health CoachingSystolic Blood Pressure124.47 mmHgStandard Deviation 1.21
Non-Health CoachingSystolic Blood Pressure127.05 mmHgStandard Deviation 1.25
Genetic Risk CounselingSystolic Blood Pressure124.71 mmHgStandard Deviation 1.2
Non-Genetic Risk CounselingSystolic Blood Pressure126.83 mmHgStandard Deviation 1.26
p-value: 0.1439Regression, Linear
p-value: 0.2275Regression, Linear
Primary

Triglycerides

Triglycerides in mg/dL

Time frame: 12 months

Population: Randomization Arms/Groups were regrouped as pre-specified in the study protocol

ArmMeasureValue (MEAN)Dispersion
Health CoachingTriglycerides149.34 mg/dLStandard Deviation 6.67
Non-Health CoachingTriglycerides135.36 mg/dLStandard Deviation 6.87
Genetic Risk CounselingTriglycerides148.3 mg/dLStandard Deviation 6.59
Non-Genetic Risk CounselingTriglycerides136.09 mg/dLStandard Deviation 7
p-value: 0.1466Regression, Linear
p-value: 0.207Regression, Linear
Primary

Waist Circumference

Waist circumference in cm

Time frame: 12 months

Population: Randomization Arms/Groups were regrouped as pre-specified in the study protocol

ArmMeasureValue (MEAN)Dispersion
Health CoachingWaist Circumference97.43 cmStandard Deviation 0.63
Non-Health CoachingWaist Circumference96.9 cmStandard Deviation 0.64
Genetic Risk CounselingWaist Circumference97.29 cmStandard Deviation 0.62
Non-Genetic Risk CounselingWaist Circumference97.04 cmStandard Deviation 0.65
p-value: 0.5557Regression, Linear
p-value: 0.7834Regression, Linear
Primary

Weight

Weight in kg

Time frame: 12 months

Population: Randomization Arms/Groups were regrouped as pre-specified in the study protocol

ArmMeasureValue (MEAN)Dispersion
Health CoachingWeight86.61 kgStandard Deviation 0.43
Non-Health CoachingWeight86.76 kgStandard Deviation 0.45
Genetic Risk CounselingWeight86.77 kgStandard Deviation 0.43
Non-Genetic Risk CounselingWeight86.59 kgStandard Deviation 0.45
p-value: 0.8027Regression, Linear
p-value: 0.7751Regression, Linear
Secondary

AF Composite Fitness Scores

Last annual fitness exam result, collected as pass or fail

Time frame: 12 months

Population: Data only collected on active duty participants as part of their annual assessment. Randomization Arms/Groups were regrouped as pre-specified in the study protocol.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Health CoachingAF Composite Fitness ScoresPass22 Participants
Health CoachingAF Composite Fitness ScoresFail0 Participants
Non-Health CoachingAF Composite Fitness ScoresFail1 Participants
Non-Health CoachingAF Composite Fitness ScoresPass5 Participants
Genetic Risk CounselingAF Composite Fitness ScoresFail1 Participants
Genetic Risk CounselingAF Composite Fitness ScoresPass17 Participants
Non-Genetic Risk CounselingAF Composite Fitness ScoresPass10 Participants
Non-Genetic Risk CounselingAF Composite Fitness ScoresFail0 Participants
p-value: 0.0512Chi-squared
p-value: 0.4478Chi-squared
Secondary

Body Mass Index (BMI)

Time frame: 12 months

Population: Randomization Arms/Groups were regrouped as pre-specified in the study protocol

ArmMeasureValue (MEAN)Dispersion
Health CoachingBody Mass Index (BMI)28.97 kg/m2Standard Deviation 0.25
Non-Health CoachingBody Mass Index (BMI)29.4 kg/m2Standard Deviation 0.25
Genetic Risk CounselingBody Mass Index (BMI)29.22 kg/m2Standard Deviation 0.25
Non-Genetic Risk CounselingBody Mass Index (BMI)29.14 kg/m2Standard Deviation 0.26
p-value: 0.2313Regression, Linear
p-value: 0.8029Regression, Linear
Secondary

Depression, as Measured by the Beck Depression Inventory (BDI)

The Beck Depression Inventory is a 21-item measure that assesses self-reported symptoms of depression. It has been heavily used in research linking depression to heart disease. Scores range from 0-63, with 0 = minimal depression and 63 = severe depression.

Time frame: 6 months

Population: Randomization Arms/Groups were regrouped as pre-specified in the study protocol

ArmMeasureValue (MEAN)Dispersion
Health CoachingDepression, as Measured by the Beck Depression Inventory (BDI)3.85 units on a scaleStandard Deviation 0.37
Non-Health CoachingDepression, as Measured by the Beck Depression Inventory (BDI)5.1 units on a scaleStandard Deviation 0.37
Genetic Risk CounselingDepression, as Measured by the Beck Depression Inventory (BDI)4.52 units on a scaleStandard Deviation 0.37
Non-Genetic Risk CounselingDepression, as Measured by the Beck Depression Inventory (BDI)4.43 units on a scaleStandard Deviation 0.38
p-value: 0.0174Regression, Linear
p-value: 0.8694Regression, Linear
Secondary

Diabetes Risk Score

Time frame: 12 months

Population: risk score data was only collected and calculated at baseline

Secondary

Fasting Blood Glucose

Adjusted for baseline

Time frame: 12 months

Population: Randomization Arms/Groups were regrouped as pre-specified in the study protocol

ArmMeasureValue (MEAN)Dispersion
Health CoachingFasting Blood Glucose99.62 mg/dLStandard Deviation 1.54
Non-Health CoachingFasting Blood Glucose100.64 mg/dLStandard Deviation 1.42
Genetic Risk CounselingFasting Blood Glucose100.13 mg/dLStandard Deviation 1.44
Non-Genetic Risk CounselingFasting Blood Glucose100.23 mg/dLStandard Deviation 1.56
p-value: 0.6289Regression, Linear
p-value: 0.9631Regression, Linear
Secondary

Framingham Risk Score (FRS)

Time frame: 12 months

Population: risk score data was only collected and calculated at baseline

Secondary

Patient Activation Score

Patient activation is the degree to which patients accept an active role in their healthcare, and have the knowledge, skills and confidence to take care of their health. When scored as a continuous variable, the range is from 0 to 100, with higher numbers indicating greater levels of patient activation.

Time frame: 12 months

Population: Randomization Arms/Groups were regrouped as pre-specified in the study protocol

ArmMeasureValue (MEAN)Dispersion
Health CoachingPatient Activation Score73.13 units on a scaleStandard Deviation 1.5
Non-Health CoachingPatient Activation Score70.95 units on a scaleStandard Deviation 1.53
Genetic Risk CounselingPatient Activation Score72.3 units on a scaleStandard Deviation 1.45
Non-Genetic Risk CounselingPatient Activation Score71.51 units on a scaleStandard Deviation 1.55
p-value: 0.3106Regression, Linear
p-value: 0.7087Regression, Linear
Secondary

Perceived Risk for Coronary Heart Disease (CHD)

Investigator developed questions assessing level of personal perceived risk, fear, anger, worry regarding CHD risk. The consequences subscale ranges from 6-30. Higher scores on the consequences represent strongly held beliefs about negative consequences of the illness. The personal control subscale ranges from 6-30 and the treatment control subscale ranges from 2-10. Higher scores on the personal control and treatment control represent positive beliefs about the controllability of the illness. The emotional representations scores range from 6-30. Higher score indicates higher levels of worry or anxiety about risk of illness.

Time frame: 6 months

Population: Randomization Arms/Groups were regrouped as pre-specified in the study protocol

ArmMeasureGroupValue (MEAN)Dispersion
Health CoachingPerceived Risk for Coronary Heart Disease (CHD)Consequences subscale23.35 units on a scaleStandard Deviation 0.53
Health CoachingPerceived Risk for Coronary Heart Disease (CHD)Personal control25.44 units on a scaleStandard Deviation 0.38
Health CoachingPerceived Risk for Coronary Heart Disease (CHD)Treatment control8.44 units on a scaleStandard Deviation 0.13
Health CoachingPerceived Risk for Coronary Heart Disease (CHD)Emotional representations13.54 units on a scaleStandard Deviation 0.37
Non-Health CoachingPerceived Risk for Coronary Heart Disease (CHD)Personal control24.42 units on a scaleStandard Deviation 0.39
Non-Health CoachingPerceived Risk for Coronary Heart Disease (CHD)Treatment control8.21 units on a scaleStandard Deviation 0.13
Non-Health CoachingPerceived Risk for Coronary Heart Disease (CHD)Emotional representations14.15 units on a scaleStandard Deviation 0.37
Non-Health CoachingPerceived Risk for Coronary Heart Disease (CHD)Consequences subscale23.55 units on a scaleStandard Deviation 0.53
Genetic Risk CounselingPerceived Risk for Coronary Heart Disease (CHD)Treatment control8.39 units on a scaleStandard Deviation 0.12
Genetic Risk CounselingPerceived Risk for Coronary Heart Disease (CHD)Personal control25.15 units on a scaleStandard Deviation 0.38
Genetic Risk CounselingPerceived Risk for Coronary Heart Disease (CHD)Emotional representations13.68 units on a scaleStandard Deviation 0.36
Genetic Risk CounselingPerceived Risk for Coronary Heart Disease (CHD)Consequences subscale24.03 units on a scaleStandard Deviation 0.52
Non-Genetic Risk CounselingPerceived Risk for Coronary Heart Disease (CHD)Emotional representations14 units on a scaleStandard Deviation 0.37
Non-Genetic Risk CounselingPerceived Risk for Coronary Heart Disease (CHD)Personal control24.62 units on a scaleStandard Deviation 0.39
Non-Genetic Risk CounselingPerceived Risk for Coronary Heart Disease (CHD)Consequences subscale22.83 units on a scaleStandard Deviation 0.53
Non-Genetic Risk CounselingPerceived Risk for Coronary Heart Disease (CHD)Treatment control8.23 units on a scaleStandard Deviation 0.13
Comparison: Perceived Risk for CHD, Consequences subscalep-value: 0.7923Regression, Linear
Comparison: Perceived Risk for CHD, Personal controlp-value: 0.0636Regression, Linear
Comparison: Perceived Risk for CHD, Treatment controlp-value: 0.2063Regression, Linear
Comparison: Perceived Risk for CHD, Emotional representationsp-value: 0.2529Regression, Linear
Comparison: Perceived Risk for coronary heart disease (CHD), Consequences subscalep-value: 0.1085Regression, Linear
Comparison: Perceived Risk for coronary heart disease (CHD), personal control subscalep-value: 0.337Regression, Linear
Comparison: Perceived Risk for coronary heart disease (CHD), treatment control subscalep-value: 0.3483Regression, Linear
Comparison: Perceived Risk for coronary heart disease (CHD), emotional representationsp-value: 0.5384Regression, Linear
Secondary

Perceived Risk for Type 2 Diabetes (T2D)

Investigator developed questions assessing level of personal perceived risk, fear, anger, worry regarding T2D risk. The consequences subscale ranges from 6-30. Higher scores on the consequences represent strongly held beliefs about negative consequences of the illness. The personal control subscale ranges from 6-30 and the treatment control subscale ranges from 2-10. Higher scores on the personal control and treatment control represent positive beliefs about the controllability of the illness. The emotional representations scores range from 6-30. Higher score indicates higher levels of worry or anxiety about risk of illness.

Time frame: 6 months

Population: Randomization Arms/Groups were regrouped as pre-specified in the study protocol

ArmMeasureGroupValue (MEAN)Dispersion
Health CoachingPerceived Risk for Type 2 Diabetes (T2D)Consequences subscale22.05 units on a scaleStandard Deviation 0.55
Health CoachingPerceived Risk for Type 2 Diabetes (T2D)Personal control24.79 units on a scaleStandard Deviation 0.36
Health CoachingPerceived Risk for Type 2 Diabetes (T2D)Treatment control8.37 units on a scaleStandard Deviation 0.14
Health CoachingPerceived Risk for Type 2 Diabetes (T2D)Emotional representations13.23 units on a scaleStandard Deviation 0.36
Non-Health CoachingPerceived Risk for Type 2 Diabetes (T2D)Personal control24.55 units on a scaleStandard Deviation 0.36
Non-Health CoachingPerceived Risk for Type 2 Diabetes (T2D)Treatment control8.18 units on a scaleStandard Deviation 0.14
Non-Health CoachingPerceived Risk for Type 2 Diabetes (T2D)Emotional representations14.66 units on a scaleStandard Deviation 0.37
Non-Health CoachingPerceived Risk for Type 2 Diabetes (T2D)Consequences subscale21.79 units on a scaleStandard Deviation 0.56
Genetic Risk CounselingPerceived Risk for Type 2 Diabetes (T2D)Treatment control8.35 units on a scaleStandard Deviation 0.13
Genetic Risk CounselingPerceived Risk for Type 2 Diabetes (T2D)Personal control25.14 units on a scaleStandard Deviation 0.35
Genetic Risk CounselingPerceived Risk for Type 2 Diabetes (T2D)Emotional representations13.75 units on a scaleStandard Deviation 0.37
Genetic Risk CounselingPerceived Risk for Type 2 Diabetes (T2D)Consequences subscale22.32 units on a scaleStandard Deviation 0.54
Non-Genetic Risk CounselingPerceived Risk for Type 2 Diabetes (T2D)Emotional representations14.18 units on a scaleStandard Deviation 0.37
Non-Genetic Risk CounselingPerceived Risk for Type 2 Diabetes (T2D)Personal control24.28 units on a scaleStandard Deviation 0.36
Non-Genetic Risk CounselingPerceived Risk for Type 2 Diabetes (T2D)Consequences subscale21.63 units on a scaleStandard Deviation 0.56
Non-Genetic Risk CounselingPerceived Risk for Type 2 Diabetes (T2D)Treatment control8.2 units on a scaleStandard Deviation 0.14
Comparison: Perceived Risk for T2D, Consequences subscalep-value: 0.7447Regression, Linear
Comparison: Perceived Risk for T2D, Personal controlp-value: 0.6378Regression, Linear
Comparison: Perceived Risk for T2D, Treatment controlp-value: 0.3209Regression, Linear
Comparison: Perceived Risk for T2D, Emotional representationsp-value: 0.0058Regression, Linear
Comparison: Perceived Risk for type 2 diabetes (T2D), Consequences subscalep-value: 0.3769Regression, Linear
Comparison: Perceived Risk for type 2 diabetes (T2D), personal controlp-value: 0.0872Regression, Linear
Comparison: Perceived Risk for type 2 diabetes (T2D), treatment controlp-value: 0.4302Regression, Linear
Comparison: Perceived Risk for type 2 diabetes (T2D), emotional representationsp-value: 0.4133Regression, Linear
Secondary

Social Isolation

Single item to assess for availability of support person, where No=no support person.

Time frame: 6 months

Population: Data is reported for participants who had data available at the 6 month visit. Randomization Arms/Groups were regrouped as pre-specified in the study protocol.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Health CoachingSocial IsolationSocial Support=No3 Participants
Health CoachingSocial IsolationSocial Support=Yes72 Participants
Non-Health CoachingSocial IsolationSocial Support=Yes69 Participants
Non-Health CoachingSocial IsolationSocial Support=No7 Participants
Genetic Risk CounselingSocial IsolationSocial Support=No8 Participants
Genetic Risk CounselingSocial IsolationSocial Support=Yes69 Participants
Non-Genetic Risk CounselingSocial IsolationSocial Support=No2 Participants
Non-Genetic Risk CounselingSocial IsolationSocial Support=Yes72 Participants
p-value: 0.558995% CI: [0.335, 7.544]Regression, Logistic
Secondary

Stages of Change

These evidence-based questions are validated and based upon the Transtheoretical Model and assess an individual's readiness to make behavioral change in 5 health behavior domains (dietary intake, exercise, weight loss, smoking cessation, and medication adherence).

Time frame: 6 months

Population: Randomization Arms/Groups were regrouped as pre-specified in the study protocol

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Health CoachingStages of ChangeExercise behavior: Contemplation9 Participants
Health CoachingStages of ChangeWeight reduction: Contemplation8 Participants
Health CoachingStages of ChangeWeight reduction: Preparation4 Participants
Health CoachingStages of ChangeWeight reduction: Action47 Participants
Health CoachingStages of ChangeWeight reduction: Maintenance10 Participants
Health CoachingStages of ChangeExercise behavior: Pre-contemplation2 Participants
Health CoachingStages of ChangeWeight reduction: Pre-contemplation2 Participants
Health CoachingStages of ChangeExercise Behavior: Preparation15 Participants
Health CoachingStages of ChangeExercise Behavior: Action29 Participants
Health CoachingStages of ChangeExercise Behavior: Maintenance20 Participants
Health CoachingStages of ChangeSmoking behavior: Pre-contemplation2 Participants
Health CoachingStages of ChangeSmoking behavior: Contemplation2 Participants
Health CoachingStages of ChangeSmoking behavior: Preparation3 Participants
Health CoachingStages of ChangeSmoking behavior: Action4 Participants
Health CoachingStages of ChangeHealthier eating behavior: Pre-contemplation2 Participants
Health CoachingStages of ChangeHealthier eating behavior: Contemplation8 Participants
Health CoachingStages of ChangeHealthier eating behavior: Preparation6 Participants
Health CoachingStages of ChangeHealthier eating behavior: Action41 Participants
Health CoachingStages of ChangeHealthier eating behavior: Maintenance13 Participants
Health CoachingStages of ChangeStress behavior: Pre-contemplation7 Participants
Health CoachingStages of ChangeStress behavior: Contemplation9 Participants
Health CoachingStages of ChangeStress behavior: Preparation8 Participants
Health CoachingStages of ChangeStress behavior: Action27 Participants
Health CoachingStages of ChangeStress behavior: Maintenance24 Participants
Non-Health CoachingStages of ChangeStress behavior: Maintenance34 Participants
Non-Health CoachingStages of ChangeSmoking behavior: Preparation2 Participants
Non-Health CoachingStages of ChangeWeight reduction: Action43 Participants
Non-Health CoachingStages of ChangeStress behavior: Action23 Participants
Non-Health CoachingStages of ChangeStress behavior: Preparation4 Participants
Non-Health CoachingStages of ChangeSmoking behavior: Action5 Participants
Non-Health CoachingStages of ChangeExercise Behavior: Action23 Participants
Non-Health CoachingStages of ChangeHealthier eating behavior: Preparation7 Participants
Non-Health CoachingStages of ChangeExercise behavior: Pre-contemplation3 Participants
Non-Health CoachingStages of ChangeHealthier eating behavior: Pre-contemplation0 Participants
Non-Health CoachingStages of ChangeWeight reduction: Preparation3 Participants
Non-Health CoachingStages of ChangeHealthier eating behavior: Contemplation9 Participants
Non-Health CoachingStages of ChangeStress behavior: Contemplation10 Participants
Non-Health CoachingStages of ChangeExercise Behavior: Maintenance13 Participants
Non-Health CoachingStages of ChangeStress behavior: Pre-contemplation4 Participants
Non-Health CoachingStages of ChangeWeight reduction: Contemplation10 Participants
Non-Health CoachingStages of ChangeExercise Behavior: Preparation20 Participants
Non-Health CoachingStages of ChangeSmoking behavior: Pre-contemplation1 Participants
Non-Health CoachingStages of ChangeExercise behavior: Contemplation16 Participants
Non-Health CoachingStages of ChangeHealthier eating behavior: Maintenance11 Participants
Non-Health CoachingStages of ChangeWeight reduction: Pre-contemplation1 Participants
Non-Health CoachingStages of ChangeSmoking behavior: Contemplation2 Participants
Non-Health CoachingStages of ChangeWeight reduction: Maintenance11 Participants
Non-Health CoachingStages of ChangeHealthier eating behavior: Action44 Participants
Genetic Risk CounselingStages of ChangeSmoking behavior: Pre-contemplation1 Participants
Genetic Risk CounselingStages of ChangeExercise behavior: Contemplation10 Participants
Genetic Risk CounselingStages of ChangeExercise Behavior: Preparation18 Participants
Genetic Risk CounselingStages of ChangeExercise Behavior: Action26 Participants
Genetic Risk CounselingStages of ChangeExercise Behavior: Maintenance21 Participants
Genetic Risk CounselingStages of ChangeStress behavior: Contemplation9 Participants
Genetic Risk CounselingStages of ChangeStress behavior: Pre-contemplation4 Participants
Genetic Risk CounselingStages of ChangeSmoking behavior: Contemplation3 Participants
Genetic Risk CounselingStages of ChangeSmoking behavior: Preparation4 Participants
Genetic Risk CounselingStages of ChangeSmoking behavior: Action5 Participants
Genetic Risk CounselingStages of ChangeStress behavior: Preparation8 Participants
Genetic Risk CounselingStages of ChangeHealthier eating behavior: Pre-contemplation1 Participants
Genetic Risk CounselingStages of ChangeHealthier eating behavior: Contemplation9 Participants
Genetic Risk CounselingStages of ChangeStress behavior: Maintenance33 Participants
Genetic Risk CounselingStages of ChangeHealthier eating behavior: Preparation8 Participants
Genetic Risk CounselingStages of ChangeHealthier eating behavior: Action41 Participants
Genetic Risk CounselingStages of ChangeStress behavior: Action22 Participants
Genetic Risk CounselingStages of ChangeWeight reduction: Pre-contemplation1 Participants
Genetic Risk CounselingStages of ChangeWeight reduction: Contemplation8 Participants
Genetic Risk CounselingStages of ChangeHealthier eating behavior: Maintenance13 Participants
Genetic Risk CounselingStages of ChangeWeight reduction: Preparation4 Participants
Genetic Risk CounselingStages of ChangeWeight reduction: Action53 Participants
Genetic Risk CounselingStages of ChangeWeight reduction: Maintenance8 Participants
Genetic Risk CounselingStages of ChangeExercise behavior: Pre-contemplation1 Participants
Non-Genetic Risk CounselingStages of ChangeStress behavior: Action28 Participants
Non-Genetic Risk CounselingStages of ChangeStress behavior: Contemplation10 Participants
Non-Genetic Risk CounselingStages of ChangeExercise Behavior: Preparation17 Participants
Non-Genetic Risk CounselingStages of ChangeWeight reduction: Pre-contemplation2 Participants
Non-Genetic Risk CounselingStages of ChangeSmoking behavior: Pre-contemplation2 Participants
Non-Genetic Risk CounselingStages of ChangeExercise Behavior: Maintenance12 Participants
Non-Genetic Risk CounselingStages of ChangeExercise behavior: Pre-contemplation4 Participants
Non-Genetic Risk CounselingStages of ChangeWeight reduction: Contemplation10 Participants
Non-Genetic Risk CounselingStages of ChangeWeight reduction: Maintenance13 Participants
Non-Genetic Risk CounselingStages of ChangeExercise Behavior: Action26 Participants
Non-Genetic Risk CounselingStages of ChangeStress behavior: Pre-contemplation7 Participants
Non-Genetic Risk CounselingStages of ChangeWeight reduction: Preparation3 Participants
Non-Genetic Risk CounselingStages of ChangeStress behavior: Preparation4 Participants
Non-Genetic Risk CounselingStages of ChangeHealthier eating behavior: Pre-contemplation1 Participants
Non-Genetic Risk CounselingStages of ChangeHealthier eating behavior: Maintenance11 Participants
Non-Genetic Risk CounselingStages of ChangeHealthier eating behavior: Contemplation8 Participants
Non-Genetic Risk CounselingStages of ChangeStress behavior: Maintenance25 Participants
Non-Genetic Risk CounselingStages of ChangeSmoking behavior: Action4 Participants
Non-Genetic Risk CounselingStages of ChangeExercise behavior: Contemplation15 Participants
Non-Genetic Risk CounselingStages of ChangeHealthier eating behavior: Preparation5 Participants
Non-Genetic Risk CounselingStages of ChangeSmoking behavior: Preparation1 Participants
Non-Genetic Risk CounselingStages of ChangeSmoking behavior: Contemplation1 Participants
Non-Genetic Risk CounselingStages of ChangeWeight reduction: Action37 Participants
Non-Genetic Risk CounselingStages of ChangeHealthier eating behavior: Action44 Participants
Comparison: Stages of Change, Weight reductionp-value: 0.925995% CI: [0.511, 2.094]Regression, Logistic
Comparison: Stages of Change, Exercise behaviorp-value: 0.008295% CI: [1.234, 4.111]Regression, Logistic
Comparison: Stages of Change, Smoking behaviorp-value: 0.295495% CI: [0.084, 2.12]Regression, Logistic
Comparison: Stages of Change, Healthier eating behaviorp-value: 0.566995% CI: [0.622, 2.376]Regression, Logistic
Comparison: Stages of Change, Stress behaviorp-value: 0.12195% CI: [0.341, 1.134]Regression, Logistic
Comparison: Weight reductionp-value: 0.835595% CI: [0.461, 1.872]Regression, Logistic
Comparison: Exercise behaviorp-value: 0.045995% CI: [1.011, 3.311]Regression, Logistic
Comparison: Smoking behaviorp-value: 0.46595% CI: [0.121, 2.629]Regression, Logistic
Comparison: Healthier eating behaviorp-value: 0.830395% CI: [0.478, 1.808]Regression, Logistic
Comparison: Stress behaviorp-value: 0.325495% CI: [0.744, 2.439]Regression, Logistic
Secondary

Total Cholesterol

Adjusted for baseline

Time frame: 12 months

Population: Randomization Arms/Groups were regrouped as pre-specified in the study protocol

ArmMeasureValue (MEAN)Dispersion
Health CoachingTotal Cholesterol212.86 mg/dLStandard Deviation 4.01
Non-Health CoachingTotal Cholesterol202.39 mg/dLStandard Deviation 4.1
Genetic Risk CounselingTotal Cholesterol207.07 mg/dLStandard Deviation 3.99
Non-Genetic Risk CounselingTotal Cholesterol208.51 mg/dLStandard Deviation 4.27
p-value: 0.071Regression, Linear
p-value: 0.8069Regression, Linear
Secondary

Unmanaged Stress as Measured by the Perceived Stress Scale (PSS)

The PSS is a 10 item survey assessing feelings and thoughts of stress. Scores range from 0-40 with higher scores indicating higher perceived stress.

Time frame: 6 months

Population: Randomization Arms/Groups were regrouped as pre-specified in the study protocol

ArmMeasureValue (MEAN)Dispersion
Health CoachingUnmanaged Stress as Measured by the Perceived Stress Scale (PSS)10.86 units on a scaleStandard Deviation 0.56
Non-Health CoachingUnmanaged Stress as Measured by the Perceived Stress Scale (PSS)11.43 units on a scaleStandard Deviation 0.56
Genetic Risk CounselingUnmanaged Stress as Measured by the Perceived Stress Scale (PSS)11.07 units on a scaleStandard Deviation 0.55
Non-Genetic Risk CounselingUnmanaged Stress as Measured by the Perceived Stress Scale (PSS)11.22 units on a scaleStandard Deviation 0.56
p-value: 0.4768Regression, Linear
p-value: 0.8452Regression, Linear

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026